MTRI · InMed Pharmaceuticals Inc. · Executive Compensation
$18.79
+0.44 (+2.37%)
At close · Nov 13
Return incl. dividend (before tax)
Q4 2021 earnings call transcript
Going-concern doubt
— flagged Nov 3, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued.”View the 10-Q filed Nov 3, 2026
Market Cap
$8.58M
Shares
549,374
Volume · Nov 13
7698
Avg daily vol (6 sessions)
62.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Bathery | director | Appointed | 2025-10-16 |
| Neil Klompas | director | Appointed | 2025-10-14 |
| Janet Grove | member of the Company's Board of Directors | Resigned | 2025-02-14 |
| Netta Jagpal | Chief Financial Officer and Corporate Secretary | Appointed | 2024-02-09 |
| Jonathan Tegge | Interim Chief Financial Officer | Resigned | 2024-02-09 |
| N. Netta "Neeta" Jagpal | Chief Financial Officer and Corporate Secretary | Appointed | 2024-02-09 |
| Jonathan Tegge | Interim Chief Financial Officer | Appointed | 2022-12-13 |
| Sarah Li | Vice President of Accounting and Controller and Principal Accounting Officer | Appointed | 2022-11-17 |
| Brenda Edwards | Interim Chief Financial Officer | Terminated | 2022-11-17 |
| Nicole Lemerond | director of the Board | Appointed | 2022-08-11 |
| Adam Cutler | Board of Directors (including from the Nominating & Corporate Governance Committee and the Audit Committee) | Resigned | 2022-08-11 |
| Michael Woudenberg | Chief Operating Officer | Appointed | 2022-07-20 |
| Michael Woudenberg | Chief Operating Officer | Appointed | 2022-07-20 |
Leadership
- Eric Adams CEO, Board Member
- N. Netta "Neeta" Jagpal CFO
- Netta Jagpal CFO
- Michael Woudenberg COO
- Sarah Li Chief Accounting Officer
- Bryan Baldasare Board Member
- John Bathery Board Member
- Neil Klompas Board Member
- Nicole Lemerond Board Member